YOUNG KWON
CIK 1733094 · Chief Financial & Bus. Officer · last filed 2026-02-11
YOUNG KWON is a Chief Financial & Bus. Officer who has filed 51 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for ADMA, was dated Feb 11, 2026. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.16M
2
51
-$6.89M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADMA | Director | 263,020 | $8.21 | $2.16M | -$898.1K | 9 | 2026-02-11 |
| MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Chief Financial & Bus. Officer | 0 | — | — | -$6.00M | 42 | 2020-10-01 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-11 | ADMA | Grant (A) | +10,690 | $0 | EDGAR |
| 2025-02-21 | ADMA | Grant (A) | −10,889 | $0 | EDGAR |
| 2024-08-27 | ADMA | Sell (S) | −60,000 | -$1.10M | EDGAR |
| 2024-02-28 | ADMA | Grant (A) | +24,040 | $0 | EDGAR |
| 2023-08-24 | ADMA | Buy (P) | +25,000 | $97.5K | EDGAR |
| 2023-03-08 | ADMA | Grant (A) | +25,815 | $0 | EDGAR |
| 2022-03-09 | ADMA | Grant (A) | +26,586 | $0 | EDGAR |
| 2021-10-26 | ADMA | Buy (P) | +100,000 | $100.0K | EDGAR |
| 2021-10-18 | ADMA | Grant (A) | — | $0 | EDGAR |
| 2020-10-01 | MOMENTA PHARMACEUTICALS INC (MNTA) Delisted | Disp (D) | −160,633 | $0 | EDGAR |